vTv Therapeutics (VTVT) analyst forecast and price target
Analyst forecast
Consensus of 6 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Maintained | Buy | $42.00 from $45.00 | Aug 6, 2026 |
| BTIG | Maintained | Buy | $57.00 from $49.00 | Jul 16, 2026 |
| Evercore ISI Group | Initiated Coverage | Outperform | $44.00 | Mar 12, 2026 |
| BTIG | Maintained | Buy | $49.00 | Mar 11, 2026 |
| BTIG | Maintained | Buy | $49.00 from $40.00 | Jan 27, 2026 |
| Roth Capital | Initiated Coverage | Buy | $58.00 | Jan 23, 2026 |
| TD Cowen | Initiated Coverage | Buy | $67.00 | Jan 5, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $47.00 from $36.00 | Dec 19, 2025 |
| BTIG | Initiated Coverage | Buy | $40.00 | Nov 19, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $36.00 | Aug 13, 2025 |
| HC Wainwright & Co. | Initiated Coverage | Buy | $36.00 | Apr 9, 2025 |
| Alliance Global Partners | Initiated Coverage | Buy | $35.00 | Dec 9, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $6.00 | Mar 7, 2023 |
Frequently asked questions
Is VTVT a buy, sell, or hold?
Analysts covering vTv Therapeutics currently average a Buy rating: 6 buy, 0 hold and 0 sell, from 6 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on VTVT?
On Aug 6, 2026, HC Wainwright & Co. maintained vTv Therapeutics at Buy with a price target of $42.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.